Irritable Bowel Syndrome (IBS) Treatment Market 2020-2026

Global Irritable Bowel Syndrome (IBS) Treatment Market Size, Share & Trends Analysis Report by Type (IBS-Constipation, IBS-Diarrhea, IBS-Mixed, and IBS-Unsubtyped) and by Drug Class (Eluxadoline, Linaclotide, Lubiprostone, and Others) and Forecast 2020-2026.

The global IBS treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of IBS, increasing geriatric population, and growing psychological stress across the globe. In addition, large number of products under clinical trial is expected to further propel the market growth during the forecast period. The IBS treatment market is classified on the basis of type and drug class. Based on type, the market is segmented into IBS-constipation, IBS-diarrhea, IBS-mixed, and IBS-unsubtyped. Based on drug class, the market is segregated into Eluxadoline, Linaclotide, Lubiprostone, and others. Among the type of IBS, the IBS-constipation is majorly treated across the globe. The market for IBS-constipation treatment is estimated to project a considerable CAGR during the forecast period. This growth is backed by the rise in number of IBS-constipation cases along with the number of drugs in clinical trial for the treatment of IBS-constipation.

Geographically, the global IBS treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured with a high spending on healthcare R&D, for the development of novel drugs, which in turn, offers growth to the IBS treatment market in North America. In addition, Europe is expected to project a considerable growth during the forecast period. This growth is backed by the rise in geriatric population and continuous growth in the research activities associated with stem cells and autoimmune diseases in the region, especially in UK, Italy, and Germany.

The global IBS treatment market is influenced by product development and advancements conducted by the market players. The key players of the IBS treatment market include Allergan PLC, Astellas Pharma, Inc., AstraZeneca PLC, Bausch Health Companies Inc., GlaxoSmithKline PLC, Ironwood Pharmaceuticals, Inc., and Takeda Pharmaceutical Co. Ltd. These players are playing a significant role in the growth of the IBS treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global IBS treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. Global IBS Treatment Market Research and Analysis by Type
2. Global IBS Treatment Market Research and Analysis by Drug Class

The Report Covers

• Comprehensive research methodology of the global IBS treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global IBS treatment market.
• Insights about market determinants which are stimulating the global market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.